EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy

Daniel J Stephenson, H Patrick MacKnight, L Alexis Hoeferlin, Sonya L Washington, Chelsea Sawyers, Kellie J Archer, Jerome F Strauss, Scott W Walsh, Charles E Chalfant

Journal of Lipid Research · 2023

DOI: 10.1016/j.jlr.2023.100377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2023. Verfasst von Daniel J Stephenson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology & Oncology, Department of Medicine, University of Virginia, Charlottesville, VA, USA. Hauptthemen laut MEDLINE: Pre-Eclampsia, Premature Birth. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NICHD NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are few early biomarkers to identify pregnancies at risk of preeclampsia (PE) and abnormal placental function. In this cross-sectional study, we utilized targeted ultra-performance liquid chromatography-ESI MS/MS and a linear regression model to identify specific bioactive lipids that serve as early predictors of PE. Plasma samples were collected from 57 pregnant women prior to 24-weeks of gestation with outcomes of either PE (n = 26) or uncomplicated term pregnancies (n = 31), and the profiles of eicosanoids and sphingolipids were evaluated. Significant differences were revealed in the eicosanoid, (±)11,12 DHET, as well as multiple classes of sphingolipids; ceramides, ceramide-1-phosphate, sphingomyelin, and monohexosylceramides; all of which were associated with the subsequent development of PE regardless of aspirin therapy. Profiles of these bioactive lipids were found to vary based on self-designated race. Additional analyses demonstrated that PE patients can be stratified based on the lipid profile as to PE with a preterm birth linked to significant differences in the levels of 12-HETE, 15-HETE, and resolvin D1. Furthermore, subjects referred to a high-risk OB/GYN clinic had higher levels of 20-HETE, arachidonic acid, and Resolvin D1 versus subjects recruited from a routine, general OB/GYN clinic. Overall, this study shows that quantitative changes in plasma bioactive lipids detected by ultra-performance liquid chromatography-ESI-MS/MS can serve as an early predictor of PE and stratify pregnant people for PE type and risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaPremature BirthPregnancyFemaleHumansInfant, NewbornTandem Mass SpectrometryPlacentaCross-Sectional StudiesSphingolipidsBiomarkersEicosanoidsAspirin

Stichwörter der Autor:innen

aspirineicosanoidspregnancysphingolipidsultra-high performance liquid chromatography electrospray ionization-MS/MS

Substanzen

SphingolipidsBiomarkersEicosanoidsAspirin

Autor:innen und Institutionen

  • Division of Hematology & Oncology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
  • Department of Biochemistry and Molecular Biology, Virginia Commonwealth University (VCU), Richmond, VA, USA.
  • Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, VA, USA.
  • Virginia Institute for Psychiatric & Behavioral Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
  • Division of Biostatistics, The Ohio State University College of Public Health, Columbus, OH, USA.
  • Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: Scott.Walsh@vcuhealth.org.

Förderung

  • BLRD VA
  • NICHD NIH HHS
  • National Institutes of Health
  • Office of the Director
  • US Department of Veterans Affairs
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Commission for Environmental Cooperation

Zitieren

APA

Stephenson, D. J., MacKnight, H. P., Hoeferlin, L. A., Washington, S. L., Sawyers, C., Archer, K. J., Strauss, J. F., Walsh, S. W., & Chalfant, C. E. (2023). Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2023.100377

Vancouver

Stephenson DJ, MacKnight HP, Hoeferlin LA, Washington SL, Sawyers C, Archer KJ, et al. Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy. Journal of Lipid Research. 2023. doi:10.1016/j.jlr.2023.100377

BibTeX
@article{Stephenson2023,
  author = {Stephenson, Daniel J and MacKnight, H Patrick and Hoeferlin, L Alexis and Washington, Sonya L and Sawyers, Chelsea and Archer, Kellie J and Strauss, Jerome F and Walsh, Scott W and Chalfant, Charles E},
  title = {Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy},
  journal = {Journal of Lipid Research},
  year = {2023},
  doi = {10.1016/j.jlr.2023.100377}
}
Kostenlos starten →